Vascular Endothelial Growth Factor B < Vascular Endothelial Growth Factor C < Vascular Endothelial Growth Factor D

Facettes : Author.f Mesh.f AffPays.f

List of bibliographic references

Number of relevant bibliographic references: 98.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000341 (2000)	M J Karkkainen [Finlande] ; R E Ferrell ; E C Lawrence ; M A Kimak ; K L Levinson ; M A Mctigue ; Kari Alitalo [Finlande] ; D N Finegold	Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.
000531 (2001)	T. M Kinen [Finlande] ; L. Jussila ; T. Veikkola ; T. Karpanen ; M I Kettunen ; K J Pulkkanen ; R. Kauppinen ; D G Jackson ; H. Kubo ; S. Nishikawa ; S. Yl Herttuala ; Kari Alitalo [Finlande]	Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.
000683 (2001)	M J Karkkainen [Finlande] ; L. Jussila ; R E Ferrell ; D N Finegold ; Kari Alitalo [Finlande]	Molecular regulation of lymphangiogenesis and targets for tissue oedema.
000778 (2001)	Marika J. Karkkainen [Finlande] ; Anne Saaristo [Finlande] ; Lotta Jussila [Finlande] ; Kaisa A. Karila [Finlande] ; Elizabeth C. Lawrence [États-Unis] ; Katri Pajusola [Suisse] ; Hansruedi Bueler [Suisse] ; Anne Eichmann [France] ; Risto Kauppinen ; Mikko I. Kettunen ; Seppo Yl Herttuala [Finlande] ; David N. Finegold [États-Unis] ; Robert E. Ferrell [États-Unis] ; Kari Alitalo [Finlande]	A model for gene therapy of human hereditary lymphedema
000987 (2002)	Jeffrey E. Gershenwald [États-Unis] ; Isaiah J. Fidler	Cancer. Targeting lymphatic metastasis.
000A17 (2002)	Kari Alitalo [Finlande] ; Peter Carmeliet	Molecular mechanisms of lymphangiogenesis in health and disease.
000A18 (2002)	Anne Saaristo [Finlande] ; Tanja Veikkola ; Berndt Enholm ; Maija Hytönen ; Johanna Arola ; Katri Pajusola ; Païvi Turunen ; Michael Jeltsch ; Marika J. Karkkainen ; Dontscho Kerjaschki ; Hansruedi Bueler ; Seppo Yl Herttuala ; Kari Alitalo [Finlande]	Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes.
000A57 (2002)	I. Quéré [France] ; M. Coupé ; V. Soulier-Sotto ; M. Evrard-Bras ; J P Laroche ; C. Janbon	[Genetics of lymphedema: from Milroy's disease to cancer investigations].
000B05 (2002)	Anne Saaristo [Finlande] ; Tanja Veikkola [Finlande] ; Tuomas Tammela [Finlande] ; Berndt Enholm [Finlande] ; Marika J. Karkkainen [Finlande] ; Katri Pajusola [Suisse] ; Hansruedi Bueler [Suisse] ; Seppo Yl Herttuala [Finlande] ; Kari Alitalo [Finlande]	Lymphangiogenic Gene Therapy With Minimal Blood Vascular Side Effects
000B44 (2002)	Andrzej Szuba [États-Unis] ; Mihaela Skobe ; Marika J. Karkkainen ; William S. Shin ; David P. Beynet ; Ned B. Rockson ; Noma Dakhil ; Stan Spilman ; Michael L. Goris ; H William Strauss ; Thomas Quertermous ; Kari Alitalo [Finlande] ; Stanley G. Rockson	Therapeutic lymphangiogenesis with human recombinant VEGF-C.
000C07 (2002)	Robert E. Ferrell [États-Unis]	Research perspectives in inherited lymphatic disease.
000C10 (2002)	Anne Saaristo [Finlande] ; Marika J. Karkkainen ; Kari Alitalo [Finlande]	Insights into the molecular pathogenesis and targeted treatment of lymphedema.
000C35 (2002)	Taija M Kinen [Finlande]	[Lymphatic growth factors play a part in metastasis formation].
000C59 (2003)	Young-Sup Yoon ; Toshinori Murayama ; Edwin Gravereaux ; Tengiz Tkebuchava ; Marcy Silver ; Cynthia Curry ; Andrea Wecker ; Rudolf Kirchmair ; Chun Song Hu ; Marianne Kearney ; Alan Ashare [États-Unis] ; David G. Jackson [Royaume-Uni] ; Hajime Kubo [Finlande] ; Jeffrey M. Isner ; Douglas W. Losordo	VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema
001755 (2004)	Marika J. Karkkainen [Finlande] ; Paula Haiko ; Kirsi Sainio ; Juha Partanen ; Jussi Taipale ; Tatiana V. Petrova ; Michael Jeltsch ; David G. Jackson ; Marja Talikka ; Heikki Rauvala ; Christer Betsholtz ; Kari Alitalo [Finlande]	Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
001784 (2004)	Judah Folkman ; Arja Kaipainen	Genes tell lymphatics to sprout or not.
001809 (2004)	S A Stacker [Australie] ; R A Hughes ; M G Achen	Molecular targeting of lymphatics for therapy.
001A36 (2004)	Pipsa Saharinen [Finlande] ; Tuomas Tammela ; Marika J. Karkkainen ; Kari Alitalo [Finlande]	Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.
001A85 (2004)	Meiko Takahashi [Japon] ; Takanobu Yoshimoto ; Hajime Kubo	Molecular mechanisms of lymphangiogenesis.
001B25 (2004)	Anne Saaristo [Finlande] ; Tuomas Tammela ; Jari Timonen ; Seppo Yla-Herttuala ; Erkki Tukiainen ; Sirpa Asko-Seljavaara ; Kari Alitalo [Finlande]	Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds.
001C79 (2004)	Jane Teas [États-Unis] ; Joan E. Cunningham ; Lindsie Cone ; Kel Jansen ; Senthil K. Raghavan ; Daniela K. Nitcheva ; Dawen Xie ; William M. Butler	Can hyperbaric oxygen therapy reduce breast cancer treatment-related lymphedema? A pilot study.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Vascular Endothelial Growth Factor C" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Vascular Endothelial Growth Factor C" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Vascular Endothelial Growth Factor C
}}

---

This area was generated with Dilib version V0.6.31. Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024